| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |